重症疾病前、中、后的阿片类药物处方模式:一项观察性研究
这项回顾性队列研究纳入某学术医院内科、创伤/外科或神经ICU的2,975例成年存活患者,比较入院前有无慢性阿片使用(OPTA)者出院后持续阿片使用的差异并识别相关因素。持续使用定义为出院后4-6个月中超过70%的天数有阿片处方。结果305例(10.2%)持续使用,其中OPTA者186/257(72%)、非OPTA者119/2,718(4.4%);OPTA与持续使用强相关(OR 57.2,95%CI 41.4-80.0)。多因素分析显示男性、手术操作和ICU无阿片天数与OPTA患者持续使用减少相关,年龄和ICU无阿片天数与非OPTA患者持续使用减少相关;ICU阿片总剂量及每日剂量与两组持续使用均无关。
要点
- 2,975例ICU存活者中305例(10.2%)出院4-6个月持续阿片处方(>70%天数)。
- 入院前慢性阿片使用(OPTA)者持续使用186/257(72%),非OPTA者119/2,718(4.4%)。
- OPTA与持续阿片使用强相关:OR 57.2(95%CI 41.4-80.0)。
- OPTA患者中男性、手术操作、ICU无阿片天数与持续使用减少相关。
- 非OPTA患者中年龄和ICU无阿片天数与持续使用减少相关;ICU阿片总剂量及每日剂量与两组持续使用均无关。
适用人群与场景
- 某学术医院内科、创伤/外科或神经ICU的成年患者,且存活出院。
诊断标准与关键阈值
- 持续阿片使用:出院后4-6个月中超过70%的天数有阿片处方。
- 入院前慢性阿片使用(OPTA):入院前有慢性阿片处方记录。
研究设计与关键结果
- 回顾性队列研究,纳入2,975例ICU存活患者,257例(8.6%)为OPTA。
- 主要结局:305例(10.2%)持续阿片使用,其中OPTA者186/257(72%),非OPTA者119/2,718(4.4%)。
- OPTA与持续阿片使用相关:OR 57.2(95%CI 41.4-80.0)。
- 多因素logistic回归显示,OPTA患者中男性、手术操作、ICU无阿片天数与持续阿片使用减少相关。
- 非OPTA患者中年龄和ICU无阿片天数与持续阿片使用减少相关。
- ICU阿片总剂量和每日剂量与两组持续使用均无关。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,ICU阿片给药持续时间是可改变的危险因素,可能减少重症疾病后的持续阿片使用;ICU阿片剂量与持续使用无关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The association between opioid therapy during critical illness and persistent opioid use after discharge is understudied relative to ICU opioid exposure and modifiable risk factors. Our objectives were to compare persistent opioid use after discharge among patients with and without chronic opioid use prior to admission (OPTA) and identify risk factors associated with persistent use.
DESIGN: Retrospective cohort study.
SETTING: Medical, trauma/surgical, or neurologic ICU at an academic hospital.
PARTICIPANTS: Adult patients surviving hospital admission.
INTERVENTIONS: Opioid use during the ICU and post-ICU stays.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was persistent opioid use accounting for greater than 70% of days 4-6 months after discharge. Among 2,975 included patients, 257 (8.6%) were classified as OPTA, and 305 (10.2%) persistently filled opioid prescriptions, including 186/257 (72%) OPTA and 119/2,718 (4.4%) with no chronic opioid fills prior to admission. Among all patients, OPTA was strongly associated with persistent opioid use (odds ratio, 57.2 [95% CI, 41.4-80.0]). Multivariable logistic regression revealed that male sex, surgical procedure, and ICU opioid-free days were associated with reduced persistent opioid use for OPTA patients. Age and ICU opioid-free days were associated with reduced persistent opioid use for non-OPTA patients. Total ICU opioid dose and dose per day of ICU exposure were not associated with persistent use for either group.
CONCLUSIONS: In this mixed cohort of ICU patients, 10.2% persistently filled opioid prescriptions 4-6 months after discharge. Although ICU opioid doses were not associated with persistent use, duration of ICU opioid administration is a modifiable risk factor that may reduce persistent opioid use after critical illness.
参考来源
- Wampole C, McKenna A, Riker RR, et al. Opioid Prescribing Patterns Before, During, and After Critical Illness: An Observational Study. Crit Care Explor. 2022. PMID: 35923596. doi:10.1097/CCE.0000000000000735
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。